← Back
$APLS All transactions

Apellis Pharmaceuticals, Inc.

A

$ Value

$0

Shares

22,087

Price

$0

Filed

May 29

Insider

Name

Boucher Kelley

Title

Chief People Officer

CIK

0002070437

Roles

Officer

Transaction Details

Transaction Date

2025-05-28

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

22,087

Footnotes

This restricted stock unit was granted on May 28, 2025. The restricted stock unit will fully vest on the first anniversary of the date of grant, subject to her continued service as an officer, or upon later termination of her service. | This represents a stock option award granted May 28, 2025 that vests over a four-year period. 25% vests one year from grant date and the remaining 75% vests monthly thereafter subject to continued service.

Filing Info

Accession No.

0001127602-25-015877

Form Type

4

Issuer CIK

0001492422

Boucher Kelley's History

Date Ticker Type Value
2026-01-28 APLS A $0
2025-09-02 APLS A $0
2025-09-02 APLS A $0
2025-06-09 APLS A $0
2025-06-09 APLS A $1.3M
2025-05-28 APLS A $0
2025-05-28 APLS A $554K

Other Insiders at APLS (90d)

Insider Bought Sold Last
Dolsten Mikael 2026-02-27
Watson David O.
General Counsel
2026-01-28
Deschatelets Pascal
Chief Scientific Officer
2026-01-28
Francois Cedric
Chief Executive Officer
2026-03-11
Sullivan Timothy Eugene
Chief Financial Officer
2026-04-17
O'Brien Stephanie Monaghan 2026-04-06
Nicholson Nur
Chief Technical Officer
2026-01-28
Chopas James George
VP/Chief Accounting Officer
2026-01-28
DeLong Mark Jeffrey
Chief Business & Strat Officer
$8K 2026-02-11
Boucher Kelley
Chief People Officer
2026-01-28
MELTZER LESLIE
Chief Research and Development
2026-01-28